VRDN
NASDAQ
$18.56
Viridian Therapeutics Inc (VRDN)
Viridian Therapeutics, Inc., a biotechnology company, develops treatments for patients with serious illnesses. The company is headquartered in Boulder, Colorado.
Sector:
Healthcare
Industry:
Biotechnology
Buy
Target: $36.12 (+94.61%)
Market Cap
$1.95B
Revenue 5Y CAGR
+111.57%
FCF 5Y CAGR
+55.97%
Free Cash Flow Yield
-15.56%
Price Chart
Valuation
Market Cap$1.95B
Forward P/E1.01
P/S29.68
P/B4.18
Profitability
Total Revenue (TTM)$71M
Gross Profit (TTM)-$269M
EBITDA-$385M
Operating Margin-82389%
EPS-$3.86
Financial Health
Free Cash Flow Yield-15.56%
Growth & Risk
EPS 5Y CAGR-32.36%
Revenue 5Y CAGR+111.57%
FCF 5Y CAGR+55.97%
Beta (5Y)1.08
Sharpe Ratio0.44